{
    "organizations": [],
    "uuid": "9bc201fea93c466d562e3f26c4bd9480925b0d40",
    "author": "",
    "url": "https://www.reuters.com/article/brief-azurrx-biopharma-announces-receipt/brief-azurrx-biopharma-announces-receipt-of-required-approvals-to-add-french-clinical-site-for-its-phase-iia-study-of-ms1819-sd-idUSFWN1PD0ON",
    "ord_in_thread": 0,
    "title": "BRIEF-AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "#Market News January 18, 2018 / 1:14 PM / in 12 minutes BRIEF-AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD Reuters Staff 1 Min Read \nJan 18 (Reuters) - Azurrx Biopharma Inc: \n* AZURRX BIOPHARMA ANNOUNCES RECEIPT OF REQUIRED APPROVALS TO ADD FRENCH CLINICAL SITE FOR ITS PHASE IIA STUDY OF MS1819-SD FOR EXOCRINE PANCREATIC INSUFFICIENCY \n* AZURRX BIOPHARMA INC - IN PARTNERSHIP WITH MAYOLY SPINDLER, RECEIVED REQUIRED APPROVALS TO ADD A FRENCH SITE TO PHASE IIA STUDY OF MS1819-SD Source text for Eikon: Further company coverage:",
    "published": "2018-01-18T15:13:00.000+02:00",
    "crawled": "2018-01-18T15:36:28.057+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "january",
        "pm",
        "minute",
        "biopharma",
        "announces",
        "receipt",
        "required",
        "approval",
        "add",
        "french",
        "clinical",
        "site",
        "phase",
        "iia",
        "study",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "azurrx",
        "biopharma",
        "inc",
        "azurrx",
        "biopharma",
        "announces",
        "receipt",
        "required",
        "approval",
        "add",
        "french",
        "clinical",
        "site",
        "phase",
        "iia",
        "study",
        "exocrine",
        "pancreatic",
        "insufficiency",
        "azurrx",
        "biopharma",
        "inc",
        "partnership",
        "mayoly",
        "spindler",
        "received",
        "required",
        "approval",
        "add",
        "french",
        "site",
        "phase",
        "iia",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}